Emerging evidence suggests GLP-1 receptor agonistsmedications licensed for type 2 diabetes and weight managementmay indirectly improve psoriasis symptoms, primarily through substantial weight loss rather than direct skin effects
It works by mimicking the function of the glucagon-like peptide-1 (GLP-1) hormone in the body
Still, this new work with cryo-EM technology may serve us as a reminder, albeit indirect, that not paying full attention to adverse effects of undetected and unmanaged hyperinsulinism, the first dimension of insulin dysregulation, leaves much to be desired
Oral Insulins and Adjunct Therapies : Although challenging to develop, oral insulin formulations remain an area of interest due to the potential benefits in patient convenience and adherence
Improved insulin sensitivity: The drug helps the body metabolize glucose more efficiently, reducing the risk of developing insulin resistance and type 2 diabetes